Ceapro Inc. Appoints Michel Regnier as Senior Vice President, Technical Operations
Executive function to oversee Edmonton site technical operations with implementation of Pilot Unit for Pressurized Gas eXpanded (PGX) Technology as...
News
Ocean Biomedical (NASDAQ: OCEA) Announces New Glioblastoma Results Validating Profound Tumor Suppression with Anti-Chi3L1 Antibody
Results published in peer-reviewed Cancer Research share novel insights into Chi3L1’s role in modulating Glioma stem cells and reinforces the...
Comera Life Sciences to Participate in Four Upcoming Conferences
WOBURN, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life...
Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument
MARLBOROUGH, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...
Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year
Asserts Certara’s leadership in advancing the development and approval of new drugs for patientsPRINCETON, N.J., April 27, 2023 (GLOBE NEWSWIRE)...
Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Investment Conference May 2, 2023
NORCROSS, Ga., April 27, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target...
PETVIVO HOLDINGS, INC. TO PRESENT AT AEGIS CAPITAL VIRTUAL CONFERENCE ON MAY 2-4, 2023
PetVivo Holdings, Inc. John Lai, Chief Executive Officer of PetVivo Holdings, Inc.MINNEAPOLIS, April 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings,...
MI4, Montreal’s powerhouse of infectious disease research, celebrates five years of innovation and philanthropy
Vincent Chiara, real estate entrepreneur and founder and President of Groupe Mach donates $1.4 million to the MUCH Foundation for...
Windtree Therapeutics Announces Publication from Its SEISMiC Pre Cardiogenic Shock Study Comparing Two Doses of Istaroxime
WARRINGTON, Pa., April 27, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is a biotechnology...
Psychedelic Science Announces Sessions and Select Featured Speakers for Science and Research Tracks for 2023 Conference
Dr. Roland Griffiths Announced to Lead Discussions on the Science and Research of Psychedelics Featured Speakers Includes Dr. Matthew Johnson,...
Humacyte, JDRF Collaborating to Develop Insulin-Producing Biovascular Pancreas to Treat Type 1 Diabetes
NEW YORK, N.Y. and DURHAM, N.C., April 27, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a biotechnology company pioneering...
Agile Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement
PRINCETON, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that...
ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences
PLEASANTON, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), a pioneer in precision medical devices for the...
Smart for Life Releases Video Showcasing New High Protein Ice Cream
Dr. Sasson Moulavi Discusses Benefits of Smart for Life’s Unique New Product CategoryMIAMI, April 26, 2023 (GLOBE NEWSWIRE) -- Smart...
AUM Biosciences to Participate in Inaugural EF Hutton Global Conference
SINGAPORE and BETHESDA, Md., April 26, 2023 (GLOBE NEWSWIRE) -- AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotechnology company...
ContraFect Announces First Patient Dosed in the Phase 1b/2 Study of Exebacase in Patients with Chronic Prosthetic Joint Infections of the Knee
YONKERS, N.Y., April 26, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery...
Allied Corp Signs Joint Venture With Blueberries Medical Corp. to Expand Product Offering and Bring Derivative Products to Global Markets
KELOWNA, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID), a leading cannabis...
T2 Biosystems Highlights New Clinical Data Presented at the ECCMID 2023 Conference
LEXINGTON, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens...
Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023
CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed...
Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023
CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...